Enhancement of Mucosal Immunogenicity of Viral Vectored Vaccines by the NKT Cell Agonist Alpha-Galactosylceramide as Adjuvant.

Singh S, Nehete PN, Yang G, He H, Nehete B, Hanley PW, Barry MA, K Sastry J. Enhancement of Mucosal Immunogenicity of Viral Vectored Vaccines by the NKT Cell Agonist Alpha-Galactosylceramide as Adjuvant. Vaccines (Basel). 2014;2(4):686-706.